The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials.
Global Vial Adaptors for Reconstitution Drug Market: Snapshot
The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries.
Read Report Overview - https://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html
The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.
Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market
On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18509
However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.
North America to Remain the Leading Regional Market during Forecast Period
In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015.
Request for Analysis of COVID-19 Impact on Vial Adaptors for Reconstitution Drug Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18509
Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.
Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific.
Buy Vial Adaptors for Reconstitution Drug Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=18509<ype=S
This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.
The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.
Browse More Trending by Transparency Market Research:
Injectable Benzodiazepine Market: https://www.transparencymarketresearch.com/injectable-benzodiazepine-market.html
Oncology Small Molecule Drugs Market: https://www.transparencymarketresearch.com/oncology-small-molecule-drugs-market.html
Protein A Resin Market: https://www.transparencymarketresearch.com/protein-a-resin-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/